https://doi.org/10.4081/reumatismo.2021.1400
Evaluation of a psychoeducational intervention including emotional intelligence to increase treatment adherence in rheumatoid arthritis (A pilot study)
Submitted: 29 January 2021
Accepted: 27 June 2021
Published: 22 November 2021
Accepted: 27 June 2021
Abstract Views: 2242
PDF: 541
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Our objective was to perform two studies: a cross-sectional study in order to identify the main psychological variables associated to treatment adherence in rheumatoid arthritis and an intervention based on psychoeducation to assess its impact on the variables identified in the first study. We measured treatment adherence, self-efficacy, beliefs about medication, emotional intelligence and disability along with personal and disease variables in the cross-sectional study and the same variables were measured in the intervention before and after the program and 3 months later in 2 groups (an experimental group and an active control group). In the cross-sectional study (N=33) we found that the variables most associated with treatment adherence were emotional clarity (r=0.352, p<0.05) and emotional repair (r=0.363, p<0.05). In the intervention, we divided the patients into 2 groups: the control group (N=7) and the intervention group (N=10). At the end of the study and at follow-up, we found a significant increase in adherence and self-efficacy in the intervention group, when compared with the control group. Emotional clarity was increased only in the post-test, and at follow up a decrease in beliefs of concern about medication was found. Psychoeducational programs based on information about the disease and its treatment together with emotional management are effective in increasing treatment adherence in the long term.
Wabe N, Lee A, Wechalekar M, et al. Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patients. Int J Clin Pract. 2019; 73: e13375
DOI: https://doi.org/10.1111/ijcp.13375
van den Bemt BJ, Zwikker HE, van den Ende CH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Exp Rev Clin Immunol. 2012; 8: 337-51.
DOI: https://doi.org/10.1586/eci.12.23
Lavielle M, Puyraimond-Zemmour D, Romand X, et al. Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review. RMD Open. 2018; 4: e000684.
DOI: https://doi.org/10.1136/rmdopen-2018-000684
Evers A WM, Kraaimaat FW, van Riel PLCM, de Jong AJL. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain. 2002; 100: 141-53.
DOI: https://doi.org/10.1016/S0304-3959(02)00274-9
Hill J, Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis. 2001; 60: 869-75.
Ravindran V, Jadhav R. The effect of rheumatoid arthritis disease education on adherence to medications and followup in Kerala, India. J Rheumatol. 2013; 40: 1460-1.
DOI: https://doi.org/10.3899/jrheum.130350
Mary A, Boursier A, Desailly Henry I, et al. Mobile phone text messages improve treatment adherence in patients taking methotrexate for rheumatoid arthritis: a randomized pilot study. Arthrit Care Res. 2019; 71: 1344-52.
DOI: https://doi.org/10.1002/acr.23750
Fernandez-Berrocal P, Extremera N, Ramos N. Validity and reliability of the Spanish modified version of the trait meta-mood scale. Psychol. Rep. 2004; 94: 751-55.
DOI: https://doi.org/10.2466/pr0.94.3.751-755
Sanjuán-Suárez P, Pérez-García AM, Bermúdez-Moreno J. Escala de autoeficacia general: datos psicométricos de la adaptación para población española. Psicothema. 2000; 12: 509-13.
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthrit Rheum. 1988; 31: 315-24.
DOI: https://doi.org/10.1002/art.1780310302
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthrit Rheum. 2010; 62: 2569-81.
DOI: https://doi.org/10.1002/art.27584
Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol. 2005; 23: S14-18.
Durán J, Domínguez A, Espinoza M. Evaluation of the Health Assessment Questionnaire Disability Index in Chilean patients with rheumatoid arthritis. Rev Med Chil. 2019; 147: 612-17.
DOI: https://doi.org/10.4067/S0034-98872019000500612
Beléndez-Vázquez M, Herández-Mijárez A, Horne R, Weinman J. Evaluación de las creencias sobre el tratamiento: validez y fiabilidad de la version española del Beliefs about Medicines questionnaire. Int J Clin Health Psychol. 2007; 7: 767-779.
Ortega Suárez FJ, Sánchez Plumed J, Pérez Valentín MA, et al. Grupo de Estudio Vatren. Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus. Nefrologia 2011; 31: 690-6.
Knobel H, Alonso J, Casado JL, et al. GEEMA Study Group. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study 2002. AIDS. 2003; 16: 605-13.
DOI: https://doi.org/10.1097/00002030-200203080-00012
Prevoo MLL, Van’T Hof MA, Kuper, HH, et al. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthrit Rheum. 1995; 38: 44-8.
DOI: https://doi.org/10.1002/art.1780380107
Treharne G, Lyons A, Kitas G. Medication adherence in rheumatoid arthritis: effects of psychosocial factors. Psychol Health Med. 2004; 9: 337-49.
DOI: https://doi.org/10.1080/13548500410001721909
De Klerk E. Measurement of patient compliance on drug therapy an overview. In Vingerhoets A (Ed.), Advances in behavioral medicine assessment. London: Harwood academic publishers; 2001.
Brus H, van de Laar M, Taal E, et al. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Couns. 1999; 36: 57-64.
DOI: https://doi.org/10.1016/S0738-3991(98)00087-1
McEwen BS, Gray JD, Nasca C. 60 Years of Neuroendocrinology: Redefining neuroendocrinology: stress, sex and cognitive and emotional regulation. J Endocrinol. 2015; 226: T67-T83.
DOI: https://doi.org/10.1530/JOE-15-0121
Irwin MR, Cole SW. Reciprocal regulation of the neural and innate immune systems. Nature Rev Immunol. 2011; 11: 625-32.
DOI: https://doi.org/10.1038/nri3042
Pariante CM. Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation. Eur Neuropsychopharmacol. 2017; 27: 554-59.
DOI: https://doi.org/10.1016/j.euroneuro.2017.04.001
How to Cite
Cárdenas-Cloud, E., Brambila-Tapia, A., Meda-Lara, R., Pérez-Vázquez, F., Chavarría-Ávila, E., Romero-Abundis, F., & Vázquez-del-Mercado, M. (2021). Evaluation of a psychoeducational intervention including emotional intelligence to increase treatment adherence in rheumatoid arthritis (A pilot study). Reumatismo, 73(3). https://doi.org/10.4081/reumatismo.2021.1400
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti, Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort , Reumatismo: Vol. 76 No. 2 (2024)
- I. Pantano, D. Mauro, D. Simone, L. Costa, D. Capocotta, M. Raimondo, D. Birra, G. Cuomo, T. D'Errico, M. Ferrucci, F. Comentale, G. Italiano, P. Moscato, N. Pappone, R. Russo, S. Scarpato, R. Tirri, P. Buono, A. Postiglione, R. Guida, R. Scarpa, U. Trama, E. Tirri, F. Ciccia, The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis , Reumatismo: Vol. 74 No. 4 (2022)
- M. Iacovantuono, S. Ferrigno, P. Conigliaro, P. Triggianese, A. D’Antonio, F.R. Spinelli, A. Bergamini, M.S. Chimenti, Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis , Reumatismo: Vol. 76 No. 1 (2024)
- A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni, Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre , Reumatismo: Vol. 64 No. 6 (2012)
- A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco, Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab , Reumatismo: Vol. 58 No. 2 (2006)
- F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, V. Coletta, C. Montecucco, Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2) , Reumatismo: Vol. 62 No. 1 (2010)
- L. Riente, The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis , Reumatismo: Vol. 56 No. s1 (2004)
- C. Botsios, P. Ostuni, S. Todesco, Incidence and management of infusion reactions to infliximab in 186 italian patient’s with rheumatoid arthritis: the Padua experience , Reumatismo: Vol. 57 No. 1 (2005)
- F. Lioté, Treatment of hyperuricemia, gout and other crystalline arthritidies , Reumatismo: Vol. 63 No. 4 (2011): Special issue • Microcrystalline Arthritis
- K.C. Meléndez-Monreal, A.J.L. Brambila-Tapia, V. González-Díaz, S. Cerpa-Cruz, S.R. Gutiérrez-Ureña, M.d.C. Yeo-Ayala, R. Robles-García, G.E. Martínez-Bonilla, Association of positive psychological variables with disease activity, functional disability and erythrocyte sedimentation rate in patients with rheumatoid arthritis: a preliminary study , Reumatismo: Vol. 74 No. 4 (2022)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
You may also start an advanced similarity search for this article.
